Nicotine polacrilex gum, coated mint flavor, is the generic equivalent of GlaxoSmithKline Consumer Healthcare’s Nicorette fresh mint gum, which is used as an aid to smoking cessation. Watson said that it will make the product available to customers in early January 2009.
Paul Bisaro, president and CEO of Watson, said: “The approval of our mint-flavored, coated nicotine gum is a significant addition to our line of generic smoking cessation products. We also have applications pending at FDA for additional flavors and look forward further enhancing our line of smoking cessation products.”